Stocks

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks Top Stock Websites Top Gainers/ Losers/ Active Stocks Dividend Stocks ChatGPT Stocks

ETFs

ETF Center Top ETFs by Upside

Top ETFs by Smart Score Top Gainers/ Losers/ Active ETFs

Crypto

Crypto Center Bitcoin

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

News Smart Portfolio Expert Center TipRanksAI

TOOLS

Earnings Calendar

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Stocks

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Top Stock Websites

Top Gainers/ Losers/ Active Stocks

Dividend Stocks

ETFs

Top ETFs by Upside

Top ETFs by Smart Score

Top Gainers/ Losers/ Active ETFs

Crypto

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Enterprise Solutions

Plans & Pricing

Education

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

FBIO Stock Latest News

Fortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference

Press ReleasesFortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023

Press ReleasesJourney Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023

2M ago

Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults

Press ReleasesJourney Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults

3M ago

Journey Medical Corporation Expects Topline Results from the Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the Treatment of Papulopustular Rosacea to be Announced Week of July 10, 2023

Press ReleasesJourney Medical Corporation Expects Topline Results from the Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the Treatment of Papulopustular Rosacea to be Announced Week of July 10, 2023

3M ago

Urica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States

Press ReleasesUrica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States

3M ago

Fortress Biotech’s Urica announces data from Phase 1 trial on dotinurad

The FlyFortress Biotech’s Urica announces data from Phase 1 trial on dotinurad

Helocyte announces $3.22M grant from NCI for Triplex Phase2 trial program

The FlyHelocyte announces $3.22M grant from NCI for Triplex Phase2 trial program

4M ago

Helocyte Announces $3.22 Million Grant from the National Cancer Institute for Triplex Phase 2 Clinical Trial Program

Press ReleasesHelocyte Announces $3.22 Million Grant from the National Cancer Institute for Triplex Phase 2 Clinical Trial Program

4M ago

Journey Medical Corporation Announces Positive Topline Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adult Subjects

Press ReleasesJourney Medical Corporation Announces Positive Topline Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adult Subjects

4M ago

Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

Press ReleasesJourney Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

4M ago

Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023

Press ReleasesJourney Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023

4M ago

Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

Press ReleasesFortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

5M ago

Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 11, 2023

Press ReleasesJourney Medical Corporation to Announce First Quarter 2023 Financial Results on May 11, 2023

Aevitas announces asset purchase agreement with 4D Molecular

The FlyAevitas announces asset purchase agreement with 4D Molecular

5M ago

Aevitas Therapeutics, a Fortress Biotech Subsidiary, Announces Asset Purchase Agreement with 4D Molecular Therapeutics for World-Wide Rights to Aevitas’ Short-Form Human Complement Factor H

Press ReleasesAevitas Therapeutics, a Fortress Biotech Subsidiary, Announces Asset Purchase Agreement with 4D Molecular Therapeutics for World-Wide Rights to Aevitas’ Short-Form Human Complement Factor H

5M ago

Trending

S&P 500

Dow Jones

Nasdaq 100

More Trending Stocks >